Фактор риска
Good trading liquidity
Фактор доходности
Greatly overvalued vs peers
В портфелях гуру
Управляющий | Фонд | Доля | Изменение доли |
|---|---|---|---|
| Стив Коэн | Point72 Asset Management | 0.0% | +0.01% |
| Кен Гриффин | Citadel Advisors LLC | 0.0% | +0.00% |
О компании
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential administrative and operational assistance.
Оценка компании
From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive
Прогноз аналитиков
The average target price of HNGE is 110 and suggests 20.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incre